Tang Jin, Li Ya-Jun, Li Qi, Mu Jun, Yang De-Yu, Xie Peng
Department of Neurology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Neurol Res. 2010 Jun;32(5):541-6. doi: 10.1179/174313209X414560. Epub 2009 Mar 23.
Tissue plasminogen activator (tPA) as a main thrombolytic drug for acute ischemic stroke remains complicated by risk of hemorrhagic transformation. However, whether endogenous tPA is also involved in hemorrhagic transformation is yet unclear.
We randomly assigned male Sprague-Dawley rats into three groups: the heparin group, the control group and the sham operated group. The ischemic rat models were induced by middle cerebral artery occlusion through intraluminal thread technique for 2 hours, followed by 24 hours of reperfusion. Heparin or saline was intermittent peritoneally injected after reperfusion. The extent of cerebral hemorrhage, the infarct volume, as well as the content and activity of endogenous tPA were evaluated. The matrix metalloproteinase 9 (MMP-9) expression and activity were also measured.
All rats receiving heparin after reperfusion were subjected to hemorrhagic transformation. Hemorrhage volume in the heparin group was remarkably present. There was significant difference between the two groups (p<0.01). In the heparin group, the expressions of endogenous tPA and MMP-9 obviously increased, while their content and activity had significant differences compared with that of the control group (p<0.01).
Endogenous tPA, through enhancement of MMP-9 expression and proteolytic activation, plays an important role in the pathogenesis of hemorrhagic transformation after cerebral reperfusion induced by heparin.
组织型纤溶酶原激活剂(tPA)作为急性缺血性卒中的主要溶栓药物,仍因出血转化风险而存在复杂性。然而,内源性tPA是否也参与出血转化尚不清楚。
我们将雄性Sprague-Dawley大鼠随机分为三组:肝素组、对照组和假手术组。采用腔内穿线技术阻断大脑中动脉2小时诱导缺血大鼠模型,随后再灌注24小时。再灌注后间歇性腹腔注射肝素或生理盐水。评估脑出血程度、梗死体积以及内源性tPA的含量和活性。还检测了基质金属蛋白酶9(MMP-9)的表达和活性。
所有再灌注后接受肝素治疗的大鼠均发生出血转化。肝素组出血体积明显增加。两组之间存在显著差异(p<0.01)。在肝素组中,内源性tPA和MMP-9的表达明显增加,而它们的含量和活性与对照组相比有显著差异(p<0.01)。
内源性tPA通过增强MMP-9表达和蛋白水解激活,在肝素诱导的脑再灌注后出血转化的发病机制中起重要作用。